What You Need to Know about California’s New Prescription Drug Monitoring Program








A new prescription drug monitoring program is going into effect that will impact many health care institutions and professionals. Effective October 2, 2018, as a result of the implementation of California Senate Bill 482, practitioners must, with limited exception, review the prescription history of their patients no more than 24 hours prior to prescribing a Schedule II, III, or IV drug for the first time and at least every four months thereafter.

View entire article here.

0 views0 comments

Recent Posts

See All